BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Astonea Labs Ltd

Pharmaceuticals

Offer Period :

27th to 29th May 2025

Astonea Labs Ltd IPO Details

IPO Date 27th to 29th May 2025 Minimum Investment ₹135000 / 2 Lots
Listing Date 2025-06-03 Maximum Investment ₹135000 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹37.67 Crores
Price ₹135 to ₹135 per share Fresh Issue ₹37.67 Crores
Lot Size 1 Lots (1000 Shares) Offer For Sale ₹ [-]
Listing At BSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per Share Shareholding Pre Issue 7721000 Shares
Issue Type Book Building - SME Shareholding Post Issue 10511000 Shares
IPO Date 27th to 29th May 2025
Listing Date 2025-06-03
Face Value ₹10 per share
Price ₹135 to ₹135 per share
Lot Size 1 Lots (1000 Shares)
Listing At BSE-SME
Total Issue Size ₹37.67 Crores
Employee Discount ₹0 per share
Issue Type Book Building - SME
Minimum Investment ₹135000 / 2 Lots
Maximum Investment ₹135000 / 1 Lots
Fresh Issue ₹37.67 Crores
Offer For Sale ₹[-] Crores
Retail Discount ₹0 Crores
Shareholding Pre Issue 7721000 Shares
Shareholding Post Issue 10511000 Shares

About Astonea Labs Ltd IPO

Established in 2017, Astonea Labs Ltd. operates as a contract manufacturer of pharmaceutical and cosmetic products for clients across India and international markets. The company is involved in producing a wide range of formulations, including antibiotics, anti-cold medicines, antihistamines, as well as drugs addressing diabetes, cardiovascular diseases, gynaecological concerns, pain relief, fungal infections, and nutritional supplements. In the cosmetic space, Astonea Labs offers personal care items for skin, hair, and oral care in multiple forms such as gels, ointments, creams, lotions, oils, and serums. All products are developed and manufactured in adherence to established pharmaceutical and cosmetic industry norms. The company also deals in the trading of raw materials and packaging components used in these sectors.
 

Astonea Labs not only caters to contract manufacturing needs but also promotes its own brands in the domestic market—“Glow Up” and “Regero”—with plans to introduce a new brand, “Avicel.” Its presence extends beyond India through exports to countries like Iraq and Yemen. The company's dual strategy of serving as a manufacturing partner and building proprietary brands helps it tap into diverse market segments while ensuring quality compliance. The IPO aims to support its expansion, branding, and operational capabilities in the fast-evolving healthcare and personal care segments.

Founding Year: 2017

Managing Director: Ashish Gulati

Astonea Labs Limited Timeline

Important dates for allocation and IPO listing.

27th May

IPO Opens

29th May

IPO Close

30th May

Allotment Date

2nd Jun

Initiation of Refund

2nd Jun

Credit of Shares to Demat Account

3rd Jun

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 98.42 72.3
Public Group 1.58 27.7

Astonea Labs Ltd IPO Reservation

QIB Shares Offered 530000(19%)
NII (HNI) Shares Offered 399000(14.3%)
Retail Shares Offered 927000(33.23%)
Anchor Investor Shares Offered 790000(28.32%)
Total Shares Offered 2790000
Total Shares With Anchor Investor 2790000

Astonea Labs Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1000 ₹135000
Retail (Max) 1 1000 ₹135000
S HNI (Min) 2 2000 ₹270000
S HNI (Max) 7 7000 ₹945000
B HNI (MIN) 8 8000 ₹1080000

Astonea Labs Ltd IPO Anchor Investor Details

Bid Date 26 May 2025
Shares Offered 0
Anchor Portion Size 0

Astonea Labs Ltd IPO Registrar

KFin Techologies Ltd
Phone Number +91-40-67162222/
Email Id einward.ris@kfintech.com
Our Website www.kfintech.com

Astonea Labs Ltd IPO Lead Manager

1. Oneview Corporate Advisors Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Astonea Labs Ltd Financial Information

Period Ended March 31, 2024 March 31, 2023 March 31, 2022
Net Worth ₹11.97 ₹8.16 ₹7.49
Reserves and Surplus ₹4.37 ₹4.16 ₹3.49
Total Borrowing ₹42.4 ₹35.99 ₹29.52

Astonea Labs Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 530000 927000 1.7491
Non Institutional Investors (NIIs) 399000 2377000 5.9574
NII(Bid amount of more than Ten Lakh Rupees) 0 0 0
NII(Bid amount of more than 2 Lakh < 10 Rupees) 399000 0 0
Retail Individual Investors (RIIs) 927000 1567000 1.6904
Total 2790000 4871000 1.7459

Strength of Astonea Labs Ltd

1. Our experienced management and dedicated employee base.

2. Scalable business model.

3. Wide and diverse range of product offerings.

4. Quality Service.

Risks Involved

1. The Company has not satisfied the annual OMFUA, under which the FDA assesses and collects fees from qualifying manufacturers of OTC monograph drugs which is mandatory to be paid by all the manufacturers of OTC drugs.

2. There have been some instances of delayed and non-filings in the past with the Registrar of Companies which may attract penalties.

3. The company is dependent on third parties for the supply of raw materials and such third parties could fails in meeting their obligations, which may have a material adverse effect on its business, results of operations and financial condition. Further its 35.47%, 41.96%, 55.74% and 33.90% of its total purchases are derived from its top 10 suppliers for Financial Years ended on March 31, 2024, March 31, 2023, March 31, 2022 and for the period ended December 31, 2024 respectively.

4. The Company, its Promoters, Directors, and Group Companies are party to certain legal proceedings. Any adverse outcome in such proceedings may have an adverse impact on its reputation, business, financial condition, results of operations, and cash flows.

5. Its business is significantly dependent on the revenue generated by manufacturing and selling the pharmaceuticals, which constitutes a substantial portion of its sales and such dependence exposes it to various risks that could materially affect its business operations, financial condition, and results of operations.

6. The company has had negative cash flows in the past. Sustained negative cash flow could adversely impact its business, financial condition, and results of operations.

7. Major revenue of the Company is generated from contract manufacturing and any adverse factors affecting the outsourcing of manufacturing by its customers could have an adverse on its business, results of operations and financial condition.

8. One of its domain names is registered under the name Astonea Foundation. Any dispute with the Astonea Foundation or other unforeseen circumstance may lead to loss of its online presence which could adversely affect its business.

9. The company does not have any long-term contracts with its suppliers. Any shortfall in the supply of its raw materials or an increase in its raw material costs, or other input costs, may adversely affect the pricing and supply of its products and have an adverse effect on its business, results of operations and financial condition.

10. The company has certain contingent liabilities which if materialized, could adversely affect its financial condition.

Why should you invest in

-

Astonea Labs Ltd Financials

Particulars For the financial year ending (in ₹ million)
 
Total Assets
Total Liabilities
Total Expenses
Total Revenue 
Profit After Tax
EBITDA
Adjusted EBITDA

Astonea Labs Limited IPO Contact Details

Astonea Labs Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2025-06-03 544409 -
INE0TG901011
₹37.67 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹135 ₹135
Open ₹137.45 ₹0
Low ₹135 ₹0
High ₹140 ₹0
Low ₹135 ₹0

Industry Outlook of Astonea Labs IPO

  • India plays a major role in supplying generic medicines and is recognised for cost-effective vaccines and treatments.

  • The Indian pharmaceutical industry is among the top three globally in terms of production volume.

  • Over the past nine years, the sector has expanded steadily at a compound annual growth rate (CAGR) of 9.43%.

  • Key segments within the industry include generic medicines, over-the-counter products, bulk drugs, vaccines, contract research and manufacturing, biosimilars, and biologics.

  • India hosts a significant number of pharmaceutical production sites approved by the US Food and Drug Administration (USFDA).

  • The country has approximately 500 Active Pharmaceutical Ingredient (API) manufacturers, contributing about 8% to the global API market.

  • The Indian cosmetics industry is experiencing a strong growth phase.

  • In 2017, the cosmetics market was valued at around US$ 11.6 billion.

  • It is expected to grow at a CAGR of 15–20% between 2017 and 2025.


Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Astonea Labs IPO.

Frequently Asked Questions

What is Astonea Labs Ltd IPO?

Answer Field

Astonea Labs Ltd IPO is a SME IPO of 27,90,000 equity shares of a face value of ₹10 aggregating up to ₹37.67 Crores. The issue is priced at ₹135 to ₹135 per share. The minimum order quantity is 1000 Shares. The IPO opens on May 27, 2025, and closes on May 29, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE-SME.

When Astonea Labs Ltd IPO will open?

Answer Field

The Astonea Labs Ltd IPO opens on May 27, 2025 and closes on May 29, 2025.

What is the lot size of Astonea Labs Ltd?

Answer Field

Astonea Labs Ltd lot size is 1000 shares, and the minimum amount required is ₹1,35,000.

How to apply for Astonea Labs Ltd IPO?

Answer Field

You can apply in Astonea Labs Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Astonea Labs Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Astonea Labs Ltd IPO will be done on May 30, 2025, and the allotted shares will be credited to your demat account by June 02, 2025.

When is Astonea Labs Ltd IPO listing date?

Answer Field

The Astonea Labs Ltd listing date is June 03, 2025.

Who is the registrar of Astonea Labs Ltd IPO?

Answer Field

The registrar of Astonea Labs Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Oneview Corporate Advisors Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Astonea Labs Ltd IPO?

Answer Field

The fresh issue size is ₹37.67 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Astonea Labs Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1000 shares and ₹1,35,000 amount.

How can I approve the UPI mandate request for Astonea Labs Ltd IPO?

Answer Field

To apply for Astonea Labs Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Astonea Labs Ltd?

Answer Field

The price of each Astonea Labs Ltd share will be ranging in between ₹135 to ₹135 per share.

What is the cut-off time for the UPI mandate for Astonea Labs Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, May 29, 2025.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • ANTHEM BIOSCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹540.0 - 570.0

  • IPO Size

    ₹33,95,00,00,000

  • Apply Now
  • SPUNWEB NONWOVEN LIMITEDSME IPO

  • Bidding Dates

    14th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹90.0 - 96.0

  • IPO Size

    ₹60,98,00,000

  • Apply Now
  • MONIKA ALCOBEV LIMITEDSME IPO Early Access

  • Bidding Dates

    16th Jul 2025 - 7th Jul 2025

  • Price Range

    ₹271.0 - 286.0

  • IPO Size

    ₹1,53,68,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Bidding Dates

    2nd Jul 2025 - 7th Jul 2025

  • Price Range

    ₹233.0 - 245.0

  • IPO Size

    ₹8,60,00,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • CRIZAC LIMITEDMainboard IPO

  • Issue Price

    245.00

  • Listing Day Close

    307.45

  • Listing Day (Gain/Loss)

    25.31

  • VANDAN FOODS LIMITEDSME IPO

  • Issue Price

    115.00

  • Listing Day Close

    118.75

  • Listing Day (Gain/Loss)

    3.48

  • NEETU YOSHI LIMITEDSME IPO

  • Issue Price

    75.00

  • Listing Day Close

    110.25

  • Listing Day (Gain/Loss)

    46.67

  • PRO FX TECH LIMITEDSME IPO

  • Issue Price

    87.00

  • Listing Day Close

    99.75

  • Listing Day (Gain/Loss)

    14.94

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.2 App Rating

icon-with-text

4 Languages

icon-with-text

₹5600+ Cr MTF Book

icon-with-text